RadNet (RDNT) Stock: Buy, Sell, or Hold?
RDNT - RadNet, Inc. Common Stock
$73.45
2.58 (3.64%)
â˛
5d:
-2.97%
30d:
-3.79%
90d:
+26.29%
WAIT
LOW Confidence
Analysis Updated: Sep 10, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When RDNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: RDNT is fairly priced but lacks strong directional signals. At 2.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: RDNT is fairly priced but lacks strong directional signals. At 2.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.17
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$26.80
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RDNT is currently trading at $73.45, which is considered fair relative to its 30-day fair value range of $71.10 to $77.24. The stock's valuation (Forward PE: 79.9) is in line with its historical norms (73.4). At these levels, the market is pricing in 2.9% annual earnings growth.
Technical Outlook: Technically, RDNT is in a strong uptrend. Immediate support is located at $70.08, while resistance sits at $77.79. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: RDNT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $94.62 (+33.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RDNT is in a strong uptrend. Immediate support is located at $70.08, while resistance sits at $77.79. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: RDNT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $94.62 (+33.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$71.10 -
$77.24
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.2%
Protect Your Profits
Holding RDNT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 33.5% below Wall St target ($94.62)
- BULLISH: Expecting earnings turnaround to 2.9% growth with 25.0% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$71.10 -
$77.24
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$4.23
(5.8%)
Support & Resistance Levels
Support Level
$70.08
Resistance Level
$77.79
Current Trend
Strong Uptrend
Technical data as of
Sep 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
79.93
Wall Street Target
$94.63
(+33.5%)
Revenue Growth (YoY)
25.0%
Earnings Growth (YoY)
-49.1%
Profit Margin
-0.9%
Valuation Premium vs History
+2.9% premium
PE vs Historical
79.9 vs 73.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.9%
(market-implied from PE analysis)
1-Year Target
$72.93
(+3%)
2-Year Target
$75.04
(+6%)
3-Year Target
$77.22
(+9%)
3-Yr Target (if PE normalizes)
(PE: 80â73)
PE COMPRESSION
$70.91
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 79.9, Growth: 72.4%)
$239.19
(+238%)
Base:
(SPY PE: 20.2, Growth: 72.4%)
$60.36
(-15%)
Bear:
(PE: 17.1, Growth: 72.4%)
$51.31
(-28%)
Share & Embed Analysis
Last updated: September 10, 2026 12:57 PM ET
Data refreshes hourly during market hours. Next update: 1:57 PM
Data refreshes hourly during market hours. Next update: 1:57 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDNT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Alma Gregory Sorensen
SELL
15000 shares
2026-03-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$638 | 52 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 60 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$338 | 48 HOLD |
Advanced RDNT Option Strategies
Professional options setups generated by AI based on today's RDNT price and gamma walls.
